Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

Neurotensin reduces glutamatergic transmission in the dorsolateral striatum via retrograde endocannabinoid signaling.

Yin HH, Adermark L, Lovinger DM.

Neuropharmacology. 2008 Jan;54(1):79-86. Epub 2007 Jun 22.

2.

Neurotensin inhibition of GABAergic transmission via mGluR-induced endocannabinoid signalling in rat periaqueductal grey.

Mitchell VA, Kawahara H, Vaughan CW.

J Physiol. 2009 Jun 1;587(Pt 11):2511-20. doi: 10.1113/jphysiol.2008.167429. Epub 2009 Apr 9.

3.
4.

Neurotensin selectively facilitates glutamatergic transmission in globus pallidus.

Chen L, Yung KK, Yung WH.

Neuroscience. 2006 Sep 15;141(4):1871-8. Epub 2006 Jul 11.

PMID:
16814931
5.

Modulation of endocannabinoid-mediated long-lasting disinhibition of striatal output by cholinergic interneurons.

Adermark L.

Neuropharmacology. 2011 Dec;61(8):1314-20. doi: 10.1016/j.neuropharm.2011.07.039. Epub 2011 Aug 5.

PMID:
21839753
6.
7.

Retrograde endocannabinoid signaling at striatal synapses requires a regulated postsynaptic release step.

Adermark L, Lovinger DM.

Proc Natl Acad Sci U S A. 2007 Dec 18;104(51):20564-9. Epub 2007 Dec 11.

8.

Endocannabinoids potentiate synaptic transmission through stimulation of astrocytes.

Navarrete M, Araque A.

Neuron. 2010 Oct 6;68(1):113-26. doi: 10.1016/j.neuron.2010.08.043.

9.

Glucocorticoids regulate glutamate and GABA synapse-specific retrograde transmission via divergent nongenomic signaling pathways.

Di S, Maxson MM, Franco A, Tasker JG.

J Neurosci. 2009 Jan 14;29(2):393-401. doi: 10.1523/JNEUROSCI.4546-08.2009.

10.
11.

Frequency-specific and D2 receptor-mediated inhibition of glutamate release by retrograde endocannabinoid signaling.

Yin HH, Lovinger DM.

Proc Natl Acad Sci U S A. 2006 May 23;103(21):8251-6. Epub 2006 May 12.

12.
13.

Subcellular localization of type 1 cannabinoid receptors in the rat basal ganglia.

Mátyás F, Yanovsky Y, Mackie K, Kelsch W, Misgeld U, Freund TF.

Neuroscience. 2006;137(1):337-61. Epub 2005 Nov 10.

PMID:
16289348
14.
15.

Polymodal activation of the endocannabinoid system in the extended amygdala.

Puente N, Cui Y, Lassalle O, Lafourcade M, Georges F, Venance L, Grandes P, Manzoni OJ.

Nat Neurosci. 2011 Nov 6;14(12):1542-7. doi: 10.1038/nn.2974.

PMID:
22057189
16.
17.

Neurotensin inhibits background K+ channels and facilitates glutamatergic transmission in rat spinal cord dorsal horn.

Kadiri N, Rodeau JL, Schlichter R, Hugel S.

Eur J Neurosci. 2011 Oct;34(8):1230-40. doi: 10.1111/j.1460-9568.2011.07846.x. Epub 2011 Sep 21.

PMID:
21936876
19.

Neurotensin inhibits glutamate-mediated synaptic inputs onto ventral tegmental area dopamine neurons through the release of the endocannabinoid 2-AG.

Kortleven C, Bruneau LC, Trudeau LE.

Neuropharmacology. 2012 Nov;63(6):983-91. doi: 10.1016/j.neuropharm.2012.07.037. Epub 2012 Jul 31.

PMID:
22884466
20.

Cholecystokinin and neurotensin inversely modulate excitatory synaptic transmission in the parabrachial nucleus in vitro.

Saleh TM, Kombian SB, Zidichouski JA, Pittman QJ.

Neuroscience. 1997 Mar;77(1):23-35.

PMID:
9044371

Supplemental Content

Support Center